These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24069039)

  • 21. [Factors influencing access to methadone maintenance treatment among injecting drug users attending antiretroviral treatment clinics in two counties, Yunnan province].
    Chen J; Cao X; Zhang B; Wu L; Yan G; Wu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jan; 37(1):68-71. PubMed ID: 26822646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment Program.
    Wang C; Shi CX; Rou K; Zhao Y; Cao X; Luo W; Liu E; Wu Z
    PLoS One; 2016; 11(2):e0147922. PubMed ID: 26906025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
    BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.
    Vickerman P; Hickman M; Judd A
    Int J Epidemiol; 2007 Apr; 36(2):396-405. PubMed ID: 17218325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
    Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China.
    Zhang L; Zhang D; Chen W; Zou X; Ling L
    PLoS One; 2013; 8(10):e76931. PubMed ID: 24116185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics.
    Alistar SS; Owens DK; Brandeau ML
    PLoS One; 2014; 9(1):e86584. PubMed ID: 24489747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence of HIV and HCV infections in patients receiving methadone maintenance treatment in Kaiyuan, Yunnan].
    Pu L; Su Y; Wang G; Bai J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Aug; 36(8):829-31. PubMed ID: 26714537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
    Roy KM; Hutchinson SJ; Wadd S; Taylor A; Cameron SO; Burns S; Molyneaux P; McIntyre PG; Goldberg DJ
    Epidemiol Infect; 2007 Apr; 135(3):433-42. PubMed ID: 16893486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users.
    Basu D; Kumar V; Sharma AK; Barnwal PK; Mattoo SK
    Asian J Psychiatr; 2013 Feb; 6(1):52-5. PubMed ID: 23380318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
    van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
    Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment.
    Eskandarieh S; Nikfarjam A; Tarjoman T; Nasehi A; Jafari F; Saberi-Zafarghandi MB
    Iran J Public Health; 2013; 42(6):588-93. PubMed ID: 23967426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China.
    Wang Z; Du J; Zhao M; Page K; Xiao Z; Mandel JS
    Asia Pac Psychiatry; 2013 Sep; 5(3):191-6. PubMed ID: 23857926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A cross-sectional survey of receiving no methadone maintenance treatment in HIV infected injecting drug users in Dehong Dai and Jingpo autonomous prefecture, Yunnan province].
    Tang RH; Ye RH; Yang YC; Yao ST; Wang JB; Zhang RM; Luo LF; Wu ZL; Long YC; Yin MS; He N; Duan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Mar; 38(3):336-340. PubMed ID: 28329935
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
    Alipour A; Haghdoost AA; Sajadi L; Zolala F
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High hepatitis C incidence in new injecting drug users: a policy failure?
    Maher L; Li J; Jalaludin B; Chant KG; Kaldor JM
    Aust N Z J Public Health; 2007 Feb; 31(1):30-5. PubMed ID: 17333606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?
    Vickerman P; Martin NK; Roy A; Beattie T; Jarlais DD; Strathdee S; Wiessing L; Hickman M;
    Drug Alcohol Depend; 2013 Sep; 132(1-2):172-81. PubMed ID: 23453261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
    Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
    Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.